Arkolith/Insider Trading/DNA/Form 4

Coen Steven P.

See remarksGinkgo Bioworks Holdings, Inc. (DNA) · full profile →Form 4 · filed Apr 14, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$213K
Net Open-Market Flow
-$213K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 13, 2026Sell(S)33K$6.41$213K50K
Apr 10, 2026Option exercise(M)28K——37K
Apr 10, 2026Option exercise(M)46K——83K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 10, 2026Option exercise(M)28K——0
Apr 10, 2026Option exercise(M)46K——0

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-025107) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML